GlassScriptPhysician profile
David Timothy Thompson
NPI 1639564800
$489.07
in general payments reported to CMS, 2019-2025
12 companies · $55.92 in 2025
The $55.92 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $56.05 · 2022: $24.49 · 2024: $30.66 · 2025: $55.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $94.06 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $76.93 | 2019-2024 | |
| Glaxosmithkline, LLC. | $66.56 | 2019-2024 | Bexsero |
| Tris Pharma INC | $58.13 | 2019 | |
| Corium, LLC | $55.92 | 2025 | Azstarys |
| Rhodes Pharmaceuticals L.P. | $53.65 | 2019 | |
| Shire North American Group INC | $17.45 | 2019 | |
| Kaleo, INC. | $16.05 | 2020 | |
| Dermira, INC. | $15.05 | 2019 | |
| Sobi, INC | $12.74 | 2019 | |
| Mission Pharmacal Company | $11.33 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.